Evaluation of the Long-term Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Treatment in Patients With Rectal Endometriosis
ENDO HIFU FU
1 other identifier
observational
140
1 country
1
Brief Summary
Evaluate the long-term effects of HIFU treatment for rectal endometriosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2021
CompletedFirst Submitted
Initial submission to the registry
September 11, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2029
September 17, 2025
September 1, 2025
8 years
September 11, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare the SF36 score assessed before HIFU treatment with that assessed in the long term after HIFU treatment.
every year during 5 years
Eligibility Criteria
All patients who received HIFU treatment for rectal endometriosis as part of studies HIFU/F/13.12, HIFU/F/20.01, and HIFU/F/21.12.
You may qualify if:
- Patients who have been treated with HIFU for rectal endometriosis included in study HIFU/F/13.12, study HIFU/F/20.01 (ENDO HIFU R1) or study HIFU/F/21.12 (ENDO HIFU R2)
- Agreeing to participate in the study
- Patients with internet access so that they can complete the questionnaires electronically.
You may not qualify if:
- Patients deprived of their liberty following a judicial or administrative decision,
- Patients under guardianship or conservatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- EDAP TMS S.A.lead
Study Sites (1)
Hopital de la Croix Rousse
Lyon, 69004, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2025
First Posted
September 17, 2025
Study Start
October 10, 2021
Primary Completion (Estimated)
September 30, 2029
Study Completion (Estimated)
September 30, 2029
Last Updated
September 17, 2025
Record last verified: 2025-09